Indian Pharma exports grow by 138 percent since 2013-14
Advertisement
New Delhi: India's pharma exports have increased 138 percent in April-October 2022-23 compared to the same period of 2013-14 when the country became the pharmacy for the world.
India's pharma exports witnessed a growth of 138 percent since April-October 2013-14, from Rs 37,987.68 crores in 2013-14 to Rs 90,324.23 crores in 2021-22.
Union Health Minister Mansukh Mandaviya in a tweet attaching an infographic of India's pharmaceutical exports over these years said India's medicine exports are heading the world.
"India is Healing The World India's export of pharma products registered a tremendous growth of 138 percent in April-October 2022 over the same period in 2013 under PM Narendra Modi ji's visionary leadership has emerged as a Global Pharma Powerhouse!" Mandaviya said in a tweet.
Prime Minister Narendra Modi in January while addressing the Davos Summit said that India was now a pharmacy to the world and is the third-largest pharma-producer in the world, adding that India saved crores of lives during the Covid-19 pandemic by supplying vaccines and essential medicines to many countries under 'One Earth One Health' vision.
"In this time of Corona, we have seen how India following the vision of 'One Earth, One Health' is saving crores of lives by giving essential medicines, and vaccines to many countries," PM Modi had said while delivering the 'state of the world' address virtually at the World Economic Forum's Davos Agenda.
Building on the outstanding performance in the previous FY 2020-21, Indian pharma exports once again registered a healthy performance in 2021-22. The pharma exports in 2021-22 sustained positive growth despite the global trade disruptions and drop in demand for COVID-related medicines.
In May, Indian pharma companies enabled by their price competitiveness and good quality, made a global mark, with 60 percent of the world's vaccines and 20 percent of generic medicines coming from India.
The share of pharmaceuticals and drugs in our global exports was 5.92 percent in May.
Indian pharma companies have a substantial share in the prescription market in the US and EU. The largest number of FDA-approved plants outside the US is in India.
Even in the year, 2020-21, Indian drugs and pharmaceuticals had registered a sharp growth amid the COVID despair, achieving an export of USD 24.4 Bn with a YoY growth of 18 percent.
The extraordinary exports growth in 2020-21 was achieved by braving the frequent lockdowns, global supply chain disruptions, and the depressed manufacturing sector. Indian pharma industry played a pivotal role in fighting against the COVID pandemic and demonstrating to the world that we continue to be a reliable and dependent partner when it comes to dealing with a global health crisis.
The Indian vaccine industry developed Covid vaccine with indigenous technology in collaboration with India's research institutions like the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) within the shortest time on par with highly developed countries like America and the EU. India provided 115 million doses of vaccines to more than 97 countries.
As part of the trade agreements, India has also signed a cooperation agreement with the UAE and Australia which will give enhanced access to Indian pharma products to these markets.
Read also: Govt approves setting up of Exports Promotion Council for Medical Devices
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.